Fidelity Investments
CTSO icon

Fidelity Investments’s Cytosorbents Corp CTSO Stock Holding History

Fidelity Investments’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-384
Closed -$245 – 5454
2025
Q4 		$245 Buy
+384
New +$295 ﹤0.01% 5201
2024
Q4 		– Sell
-285
Closed -$428 – 5602
2024
Q3 		$428 Hold
285
– – ﹤0.01% 4984
2024
Q2 		$200 Buy
+285
New +$247 ﹤0.01% 4920
2022
Q3 		– Sell
-90
Closed – – 4922
2022
Q2 		$0 Sell
90
-236
-72% -$542 ﹤0.01% 4977
2022
Q1 		$1K Buy
+326
New +$1.17K ﹤0.01% 4769
2021
Q3 		– Sell
-1
Closed – – 4433
2021
Q2 		$0 Buy
+1
New +$8 ﹤0.01% 4331
2019
Q3 		– Sell
-69
Closed – – 3826
2019
Q2 		$0 Buy
+69
New +$474 ﹤0.01% 3783

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Fidelity Investments's CTSO Position: Q1 2026 in Review

Fidelity Investments sold out of Cytosorbents Corp (CTSO) in Q1 2026, closing a stake of 384 shares — an estimated $245 sold.

Fidelity Investments first reported a position in CTSO in Q2 2019 and held it in 7 quarters. The position peaked at $1K in Q1 2022. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Fidelity Investments reported no remaining Cytosorbents Corp position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 384 Cytosorbents Corp shares in Q1 2026, an estimated $245.
  • Fidelity Investments first reported a position in Cytosorbents Corp in Q2 2019 and held it in 7 quarters.
  • Fidelity Investments's Cytosorbents Corp position peaked at $1K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.